COPPERLEAF TECHNOLOGIES (CPLF.CA)

CA21766N1096 - Common Stock

11.99  +0.01 (+0.08%)

Fundamental Rating

3

Taking everything into account, CPLF scores 3 out of 10 in our fundamental rating. CPLF was compared to 70 industry peers in the Software industry. CPLF scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CPLF is valued quite expensive, but it does show an excellent growth.



1

1. Profitability

1.1 Basic Checks

In the past year CPLF has reported negative net income.
CPLF had a negative operating cash flow in the past year.
CPLF had negative earnings in each of the past 5 years.
CPLF had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -10.45%, CPLF perfoms like the industry average, outperforming 54.41% of the companies in the same industry.
The Return On Equity of CPLF (-16.86%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -10.45%
ROE -16.86%
ROIC N/A
ROA(3y)-13.02%
ROA(5y)-16.53%
ROE(3y)-19.6%
ROE(5y)-50.22%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CPLF has a Gross Margin of 71.92%. This is in the better half of the industry: CPLF outperforms 73.53% of its industry peers.
CPLF's Gross Margin has declined in the last couple of years.
CPLF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.19%
GM growth 5Y-1.75%

5

2. Health

2.1 Basic Checks

CPLF does not have a ROIC to compare to the WACC, probably because it is not profitable.
CPLF has more shares outstanding than it did 1 year ago.
CPLF has a worse debt/assets ratio than last year.

2.2 Solvency

CPLF has an Altman-Z score of 8.85. This indicates that CPLF is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CPLF (8.85) is better than 89.71% of its industry peers.
CPLF has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.02, CPLF is in the better half of the industry, outperforming 69.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 8.85
ROIC/WACCN/A
WACC9.04%

2.3 Liquidity

A Current Ratio of 2.83 indicates that CPLF has no problem at all paying its short term obligations.
CPLF has a Current ratio of 2.83. This is in the better half of the industry: CPLF outperforms 79.41% of its industry peers.
CPLF has a Quick Ratio of 2.83. This indicates that CPLF is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.83, CPLF is in the better half of the industry, outperforming 79.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.83
Quick Ratio 2.83

7

3. Growth

3.1 Past

CPLF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.98%, which is quite impressive.
The Revenue has grown by 24.35% in the past year. This is a very strong growth!
CPLF shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.80% yearly.
EPS 1Y (TTM)48.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)24.35%
Revenue growth 3Y21.36%
Revenue growth 5Y18.8%
Sales Q2Q%47%

3.2 Future

The Earnings Per Share is expected to grow by 27.78% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 26.66% on average over the next years. This is a very strong growth
EPS Next Y46.55%
EPS Next 2Y27.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year30.76%
Revenue Next 2Y26.66%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

CPLF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CPLF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CPLF's earnings are expected to grow with 27.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.78%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CPLF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COPPERLEAF TECHNOLOGIES

TSX:CPLF (8/30/2024, 7:00:00 PM)

11.99

+0.01 (+0.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap943.38M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.45%
ROE -16.86%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 71.92%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.83
Quick Ratio 2.83
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)48.98%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y46.55%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)24.35%
Revenue growth 3Y21.36%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y